Anaplastic large cell lymphoma. A retrospective study of 60 patients with an aggressive clinical behaviour and multiple relapses;Reconsideración clínico-morfológica del linfoma anaplásico. Estudio retrospectivo de 60 pacientes con clínica agresiva y recidivas múltiples

Revista Clinica Espanola

Volumn 196, Issue 12, 1996, Pages 821-827

  Ageitos, A G ^a   Rivas, C ^a,b   Lobo, F ^a   Obeso, G ^a   Marcos, B ^a   Gonzalo, I ^a   Echezarreta, G ^a   Delgado, R G ^a   Oliva, H ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Depto de Anat Patologica   (Spain)

Author keywords

Aggressive Hodgkin s disease; ALCL; Anaplastic lymphoma; Clinical course HD; Flow cytometry

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; HUMAN; LARGE CELL LYMPHOMA; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; LYMPHOMA, LARGE-CELL, KI-1; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0030339172     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66:848-858.
2. Kadin ME, Sako D, Berliner M, et al Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood 1986, 68:1.042-1.049.
3. Chott A, Kaserer K, Augustin I, et al Ki-1 positive large cell lymphoma a clinicopathologic study of 41 cases. Am J Surg Pathol 1990: 14:439-448
4. Rivas C, Piris A, Gamallo C, et al Ultrastructure of 26 cases of Ki-1 lymphomas: morphoimmunologic correlation Ultrastructural Pathol 1990, 14.381-397
5. Rivas C, Obeso G, Piris M, et al. Linfomas no Hodgkin Ki-1. Estudio multihospitalario de 21 casos. Rev Clín Esp 1989; 184.238-244.
6. Greer JP, Kinney MC, Collins RD, et al. Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma J Clin Oncol 1991; 9:539-547.
7. Nakamura S, Takagi N, Kojima M, et al. Clinicopathologic study of large cell anaplastic lymphoma (Ki-1 positive large cell lymphoma). Cancer 1991; 68.118-129.
8. Shulman LN, Fnsard B, Antin JH, et al Primary Ki-1 anaplastic large cell lymphoma in adults: clinical characteristics and therapeutic outcome. J Clin Oncol 1993, 11 937-942
9. Kadin ME Primary Ki-1-positive anaplastic large-cell lymphoma: a distinct clinicopathologic entity. Ann Oncol 1994; 5.25-30.
10. Obeso G, González-Ageitos A, Lobo F, Marcos B, Rivas C Ki-1 anaplastic large-cell lymphoma. clinico-pathological correlation of 32 cases Arq Patol 1994; 26-55-62
11. Leoncini L, Del Vecchio MT. Kraft R Hodgkin's disease and CD30-positive anaplastic large cell lymphomas A continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study. Am J Pathol 1990; 137:1.047-1.057.
12. Rosso R, Paulli M, Magrini U, Kind I. Anaplastic large cell lymphoma. CD30/Ki-1 positive, expressing the CD15/Leu-M1 antigen. Immunohistochemical and morphological relationship to Hodgkin's disease. Virchows Arch A Pathol Anat 1990; 416:226-235.
13. Stricker JG, Michie SA, Warnke RA, Dorfman RF The «syncytial variant» of nodular sclerosing Hodgkin's disease. Am J Surg Pathol 1986; 10:470-477.
14. Pilen S, Mazza P, Zinzani PL. Ki-1 lymphoma and Hodgkin's disease. Haematologica 1989; 74:333-334.
15. Warnke RA. The distinction of Hodgkin's disease from B-cell lymphoma. Sern Diagn Pathol 1992; 9:284-290.
16. Banks PM. The distinction of Hodgkin's disease from T-cell lymphoma. Sern Diagn Pathol 1992; 9:279-283.
17. Rivas C, Ageitos AG, Oliva H. Linfoma anaplásico versus enfermedad de Hodgkin Diagnóstico. Controversias. Sangre 1995; 40.265-268.
18. Martínez B, Gonzalo I, Robledo M, et al Linfomas anaplásicos de célula grande estudio genético e inmunofenotipico. Sangre 1995; 40:293-299.
19. Gonzalo I, Santon A, Manzanal A, Marcos B, Ageitos A, Bellas C, Rivas C Expresión de la proteína latente de membrana (LMP) en linfomas anaplásicos de célula grande. Sangre 1995; 40:289-292.
20. Borowitz MJ, Croker BP, Burchette J. Immunocytochemical detection of lymphocyte surface antigens in fixed tissue sections J Histochem Cytochem 1982; 30:171-174.
21. Cordell JL, Falini B, Erber WN. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32:219-229.
22. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry J Histochem Cytochem 1983; 31.1 333-1.335.
23. Chabner BA, Johnson RE, Young RC. Sequential non-surgical and surgical staging of non-Hodgkin's lymphoma. Ann Intern Med 1976, 35:149-154.
24. Aisenberg AC. The staging of Hodkin's disease. J Exp Clin Cancer Res 1983; 2.209-212.
25. Bearhs OH, Earl Henson D, Hutter RVP, Kenndy BJ, eds. Hodgkin's disease. Staging of cancer Filadelfia: Ed Lippincott. 1992. 257-259
26. Kaplan EL, Meier P. Non-parametric estimating from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
27. Peto R, Pike MC, Armitage P Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35:1-39.
28. Mertz H, Housiau FA, Orscheskek K, Renauld JC, Fliedner A, Herin M. Interieukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large anaplastic lymphoma. Blood 1991; 78:1.311-1 317.
29. Modi WS, Pollock DD, Mock BA. Regional localization of the human glutaminase (GLS) and interleukin-9 (IL-9) genes by in situ hybrization. Cytogenet Cell Genet 1991, 57:114-116.
30. Orscheschek K, Merz H, Hell J, Binder T, Bartels H, Feller AC. Large cell anaplastic lymphoma-specific traslocation (t[2,5] [p23;q35]) in Hodgkin's disease: indications of a common pathogenesis? Lancet 1995; 345:87-90.
31. Blancher A, Al Saati T, Morty Y, Delsol G. Mouse monoclonal antibodies against H et Y determinant produce hybridomas from lymphocytes of athymic nude mice. Proceedings of the Symposium of International Society of Blood Transfusion on Monoclonal Antibodies against Human Red Blood Cells and Related Antigens París: Ed. Rouger Ph. Solrnon Ch. 1988; 220-223.
32. Penny RJ, Blaustein JC, Longtine JA, Pinkus GS. Ki-1 positive large cell lymphomas, a heterogenous group of neoplasms Morphologic, immunophenotypic, genotypic, and clinical features of 24 cases. Cancer 1991; 68:362-373.
33. Chan JKC, Ng CS, Hui PK, Leung TW. Anaplastic large cell Ki-1 lymphoma Delineation of two morphological types Histopathology 1989, 15:11-34.
34. Agnarsson BA, Kadin ME. Ki-1 positive large cell lymphoma A morphologic and immunologic study of 19 cases. Am J Surg Pathol 1988: 12.264-274
35. Pinkus G, Thomas P, Said J. Leu-M1 - a marker for Reed - Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues. Am J Pathol 1985, 119.244-252.
36. Oliva Aldamiz H Anatomía patológica de la enfermedad de Hodgkin Rev Cancer 1989: 3:55-62.
37. Chan JCK, Banks PM, Clearly ML, et al. A proposal for classification of lymphoid neoplasms (by the International Lymphoma Study Group) Histopathology 1994; 25.517-536.
38. Offit K, Ladariyi M, Gangi MD. Ki-1 antigen expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma. Leukemia 1990, 4:625-629.
39. Mangum M, Casey T, Cousar J, et al Monomorphic lymphomas and Hodgkin's disease. Proc Am Soc Clin Oncol 1987: 6:202A.
40. Bruin PC, Beljaards RC, Van Heerde P, et al. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype. Histopathology 1993, 23.127-135
41. Salhany KE, Collins RD, Greer JP, Kinney MC. Long-term survival in Ki-1 lymphoma Cancer 1991; 67:516-522.
42. Menestrina F, Chilosi M, Scarpa A. Nodular lymphocyte predominant Hodgkin's disease and anaplastic large-cell (CD30+) lymphoma: distinct entities or nonspecific patterns? Semin Diagn Pathol 1995, 12:256-269.
43. Ageitos AG. Linfoma anaplástico de células grandes Ki-1 positivo versus enfermedad de Hodgkin: controversies y correlación clínico-patológica. Tesis doctoral. Apto cum laude. Universidad Autónoma de Madrid. 1994.
44. Siebert JD, Stuckey JH, Kurtin PJ, Banks PM, Extranodal lymphocyte predominance Hodgkin's disease. Clinical and pathologic features. Am J Clin Pathol 1995; 103:485-491.
45. Delabie J, Weisenburger DD, Chan WC. Hodgkin's disease: a monoclonal lymphoproliferative disorder? Histopathology 1995; 27.93-96
46. Manzanal A, Santon A, Oliva H, Bellas C. Evaluation of clonal immunoglobulin heavy chain rearrangements in Hodgkin's disease using the polymerase chain reaction (PCR). Histopathology 1995; 27:21-25.
47. Hummel M, Ziemann K, Lammert H, Pileri S, Sabattini E, Stein H. Hodgkin's disease with monoclonal and polyclonal populations of RecdSternberg cells NEJM 1995, 333:901-906.